haha! Quality doesn't stay down for long after a correction, gotta get in quick IMO. ORG and QBE have horrid ROE, TLS better but still expensive given growth. Look at CTN for good value, or CYA.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
